Skip to main content
SpringerLink
Log in
Book cover

Moodiness in ADHD pp 91–109Cite as

Depressive Disorders and ADHD

  • Chapter
  • First Online:

Abstract

Major and minor depressive disorders occur 5.5 times more often in people with attention-deficit/hyperactivity disorder (ADHD) than without it. Patients with depressive disorders and ADHD (Dep/ADHD) have significant long-term impairment and suicide risk. Dep/ADHD typically begins several years after the onset of the ADHD, offering the opportunity to prevent it in this predisposed group with ADHD. Impairment related to the ADHD and to other comorbid disorders, environmental adversities, and familial factors all may contribute to the increased risk of depressive disorders and suicide in patients with ADHD. Early identification could lead to earlier treatment, which could reduce the morbidity and mortality of Dep/ADHD, but is complicated by the overlap of depression symptoms with ADHD’s and other common comorbidities’ symptoms, and with the side effects of ADHD medications. Growing evidence suggests the benefit of treating Dep/ADHD with selective serotonergic reuptake inhibitor antidepressants, stimulants, and even atomoxetine or bupropion. Other evidence suggests the benefit of psychosocial treatments, alone or with pharmacotherapy, to target the depressive symptoms, psychosocial impairment, and contributing environmental factors. This chapter reviews the morbidity, etiological factors, and strategies for assessing and treating Dep/ADHD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1996;35(11):1427–39.

    Article  CAS  PubMed  Google Scholar 

  2. Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG. Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord. 1994;30(1):15–26.

    Article  CAS  PubMed  Google Scholar 

  3. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatr. 2006;163:716.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999;40(1):57–87.

    Article  CAS  PubMed  Google Scholar 

  5. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119–38.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 2nd ed. New York: Guilford Press; 1998. 628 p.

    Google Scholar 

  7. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(04):524–40.

    Article  PubMed  Google Scholar 

  8. Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry. 2012;69(12):1295–303.

    Article  PubMed  PubMed Central  Google Scholar 

  9. James A, Lai FH, Dahl C. Attention deficit hyperactivity disorder and suicide: a review of possible associations. Acta Psychiatr Scand. 2004;110(6):408–15.

    Article  CAS  PubMed  Google Scholar 

  10. Biederman J, Ball SW, Monuteaux MC, Mick E, Spencer TJ, McCreary M, et al. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry. 2008;47(4):426–34.

    Article  PubMed  Google Scholar 

  11. Blackman GL, Ostrander R, Herman KC. Children with ADHD and depression: a multisource, multimethod assessment of clinical, social, and academic functioning. J Atten Disord. 2005;8(4):195–207.

    Article  PubMed  Google Scholar 

  12. Daviss WB, Weinman DR, Diler RS, Birmaher B, editors. Risk factors for comorbid depression in adolescents with ADHD. Poster, 53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 2006; San Diego, CA.

    Google Scholar 

  13. Rohde P, Clarke GN, Lewinsohn PM, Seeley JR, Kaufman NK. Impact of comorbidity on a cognitive-behavioral group treatment for adolescent depression. J Am Acad Child Adolesc Psychiatry. 2001;40(7):795–802.

    Article  CAS  PubMed  Google Scholar 

  14. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–23.

    Article  CAS  PubMed  Google Scholar 

  15. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552–62.

    Article  CAS  PubMed  Google Scholar 

  16. Zalsman G, Brent DA, Weersing VR. Depressive disorders in childhood and adolescence: an overview: epidemiology, clinical manifestation and risk factors. Child Adolesc Psychiatr Clin N Am. 2006;15(4):827–41.

    Article  PubMed  Google Scholar 

  17. Faraone SV, Biederman J. Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis. 1997;185(9):533–41.

    Article  CAS  PubMed  Google Scholar 

  18. Drabick DA, Gadow KD, Sprafkin J. Co-occurrence of conduct disorder and depression in a clinic-based sample of boys with ADHD. J Child Psychol Psychiatry. 2006;47(8):766–74.

    Article  PubMed  Google Scholar 

  19. Biederman J, Mick E, Faraone SV. Depression in attention deficit hyperactivity disorder (ADHD) children: “true” depression or demoralization? J Affect Disord. 1998;47(1-3):113–22.

    Article  CAS  PubMed  Google Scholar 

  20. Wilens TE, Spencer TJ. The stimulants revisited. Child Adolesc Psychiatr Clin N Am. 2000;9(3):573–603, viii.

    CAS  PubMed  Google Scholar 

  21. Pliszka SR. Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action. Neuropsychol Rev. 2007;17(1):61–72.

    Article  PubMed  Google Scholar 

  22. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry. 2003;54(12):1317–29.

    Article  CAS  PubMed  Google Scholar 

  23. Carlezon WA Jr, Mague SD, Andersen SL. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry. 2003;54(12):1330–7.

    Article  CAS  PubMed  Google Scholar 

  24. Daviss WB, Birmaher B, Diler RS, Mintz J. Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression? J Child Adolesc Psychopharmacol. 2008;18(3):257–64.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009;124(1):71–8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chen Q, Sjölander A, Runeson B, D’Onofrio BM, Lichtenstein P, Larsson H. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study. BMJ. 2014;348:g3769.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Birmaher B, Brent D, Bernet W, Bukstein O, Walter H, Benson RS, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503–26.

    Article  PubMed  Google Scholar 

  28. Daviss WB. A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J Child Adolesc Psychopharmacol. 2008;18(6):565–71.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.

    Article  PubMed  Google Scholar 

  30. Jensen PS, Rubio-Stipec M, Canino G, Bird HR, Dulcan MK, Schwab-Stone ME, et al. Parent and child contributions to diagnosis of mental disorder: are both informants always necessary? J Am Acad Child Adolesc Psychiatry. 1999;38(12):1569–79.

    Article  CAS  PubMed  Google Scholar 

  31. Kovacs M. A developmental perspective on the methods and measures in the assessment of depressive disorders: the clinical interview. In: Rutter M, Izard CE, Read PB, editors. Depression in young people: Developmental and clinical perspectives. New York City: Guilford; 1986. p. 435–65.

    Google Scholar 

  32. Diler RS, Daviss WB, Lopez A, Axelson D, Iyengar S, Birmaher B. Differentiating major depressive disorder in youths with attention deficit hyperactivity disorder. J Affect Disord. 2007;102(1–3):125–30.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Daviss WB, Birmaher B, Melhem NA, Axelson DA, Michaels SM, Brent DA. Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry. 2006;47(9):927–34.

    Article  PubMed  Google Scholar 

  34. Shea K, Daviss WB, editors. Caregiver depressive symptoms predict discrepancies between caregiver, teacher, and youth ratings of psychopathology in adolescents with ADHD. Poster, 60th annual meeting of the American Academy of Child and Adolescent Psychiatry; 2013; Orlando, FL.

    Google Scholar 

  35. Hoza B, Pelham WE, Milich R, Pillow D, McBride K. The self-perceptions and attributions of attention deficit hyperactivity disordered and nonreferred boys. J Abnorm Child Psychol. 1993;21(3):271–86.

    Article  CAS  PubMed  Google Scholar 

  36. Pelham WE Jr, Fabiano GA, Massetti GM. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol. 2005;34(3):449–76.

    Article  PubMed  Google Scholar 

  37. Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2003;42(9):1015–37.

    Article  PubMed  Google Scholar 

  38. Myers K, Winters NC. Ten-year review of rating scales. II: scales for internalizing disorders. J Am Acad Child Adolesc Psychiatry. 2002;41(6):634–59.

    Article  PubMed  Google Scholar 

  39. Johnson JG, Harris ES, Spitzer RL, Williams JB. The Patient Health Questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30(3):196–204.

    Article  PubMed  Google Scholar 

  40. Costello EJ, Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry. 1988;27(6):726–37.

    Article  CAS  PubMed  Google Scholar 

  41. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60–73.

    Article  CAS  PubMed  Google Scholar 

  42. Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry. 1995;152(12):1793–9.

    Article  CAS  PubMed  Google Scholar 

  43. Daviss WB, Nery FG, Olvera RL, Diler RS, Mezzomo KM, Soares JC, editors. Exploratory factor analysis of the CDRS-R in youths with ADHD poster. 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 2007; Boston, MA.

    Google Scholar 

  44. American Psychological Association. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: APA; 2013.

    Book  Google Scholar 

  45. Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry. 1982;39(5):549–55.

    Article  CAS  PubMed  Google Scholar 

  46. Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry. 1994;33(4):461–8.

    Article  CAS  PubMed  Google Scholar 

  47. Goodman DW, Thase ME. Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management. Postgrad Med. 2009;121(5):20–30.

    Article  PubMed  Google Scholar 

  48. Applegate B, Lahey BB, Hart EL, Biederman J, Hynd GW, Barkley RA, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1211–21.

    Article  CAS  PubMed  Google Scholar 

  49. Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187–201.

    Article  PubMed  Google Scholar 

  50. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996;35(4):409–32.

    Article  CAS  PubMed  Google Scholar 

  51. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073–86.

    Article  Google Scholar 

  52. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder. J Clin Psychopharmacol. 2002;22(3):267–74.

    Article  CAS  PubMed  Google Scholar 

  53. DuPaul GJ, Barkley RA, McMurray MB. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry. 1994;33(6):894–903.

    Article  CAS  PubMed  Google Scholar 

  54. Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996;35(10):1314–21.

    Article  CAS  PubMed  Google Scholar 

  55. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001;158(2):282–8.

    Article  CAS  PubMed  Google Scholar 

  56. Cheung AH, Emslie GJ, Mayes TL. The use of antidepressants to treat depression in children and adolescents. Can Med Assoc J. 2006;174(2):193–200.

    Article  Google Scholar 

  57. Hughes CW, Emslie GJ, Crismon ML, Posner K, Birmaher B, Ryan N, et al. Texas Children’s Medication Algorithm Project: update from Texas consensus conference panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(6):667–86.

    Article  PubMed  Google Scholar 

  58. Kratochvil CJ, Vitiello B, Walkup J, Emslie G, Waslick BD, Weller EB, et al. Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? J Child Adolesc Psychopharmacol. 2006;16(1–2):11–24.

    Article  PubMed  Google Scholar 

  59. Leslie LK, Newman TB, Chesney PJ, Perrin JM. The Food and Drug Administration’s deliberations on antidepressant use in pediatric patients. Pediatrics. 2005;116(1):195–204.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Friedman RA, Leon AC. Expanding the black box—depression, antidepressants, and the risk of suicide. N Engl J Med. 2007;356(23):2343–6.

    Article  CAS  PubMed  Google Scholar 

  61. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683–96.

    Article  CAS  PubMed  Google Scholar 

  62. Friedman RA. Antidepressants’ black-box warning—10 years later. N Engl J Med. 2014;371(18):1666–8.

    Article  PubMed  Google Scholar 

  63. Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol. 1993;3(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  64. Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol. 1996;6(3):165–75.

    Article  CAS  PubMed  Google Scholar 

  65. Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry. 2001;40(3):307–14.

    Article  CAS  PubMed  Google Scholar 

  66. Golubchik P, Kodesh A, Weizman A. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood? Clin Neuropharmacol. 2013;36(5):141–5.

    Article  CAS  PubMed  Google Scholar 

  67. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807–20.

    Article  CAS  PubMed  Google Scholar 

  68. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ, et al. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol. 2007;17(4):407–19.

    Article  PubMed  Google Scholar 

  70. Weimer K, Gulewitsch MD, Schlarb AA, Schwille-Kiuntke J, Klosterhalfen S, Enck P. Placebo effects in children: a review. Pediatr Res. 2013;74(1):96–102.

    Article  PubMed  Google Scholar 

  71. Lilly. Prescribing Information for Strattera® (Atomoxetine). Indianapolis: Lilly USA, LLC; 2015. http://pi.lilly.com/us/strattera-pi.pdf

    Google Scholar 

  72. Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, et al. The Texas Children’s Medication Algorithm Project: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I. J Am Acad Child Adolesc Psychiatry. 2000;39(7):908–19.

    Article  CAS  PubMed  Google Scholar 

  73. Hughes CW, Emslie GJ, Crismon ML, Wagner KD, Birmaher B, Geller B, et al. The Texas Children’s Medication Algorithm Project: report of the Texas consensus conference panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry. 1999;38(11):1442–54.

    Article  CAS  PubMed  Google Scholar 

  74. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642–57.

    Article  PubMed  Google Scholar 

  75. Guy W. ECDEU assessment manual for psychopharmacology, revised. Rockville: U.S. Department of Health, Education and Welfare; 1976.

    Google Scholar 

  76. Kratochvil CJ, Newcorn JH, Arnold LE, Duesenberg D, Emslie GJ, Quintana H, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005;44(9):915–24.

    Article  PubMed  Google Scholar 

  77. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275–89.

    Article  PubMed  Google Scholar 

  78. Evans SW, Owens JS, Bunford N. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2014;43(4):527–51.

    Article  PubMed  Google Scholar 

  79. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JMJ, et al. Efficacy of meta-cognitive therapy (MCT) for adult ADHD. Am J Psychiatry. 2010;167(8):958–68.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Chan E, Fogler JM, Hammerness PG. Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. JAMA. 2016;315(18):1997–2008.

    Article  CAS  PubMed  Google Scholar 

  81. Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV. Advances in understanding and treating ADHD. BMC Med. 2011;9(1):1–12.

    Article  Google Scholar 

  82. David-Ferdon C, Kaslow NJ. Evidence-based psychosocial treatments for child and adolescent depression. J Clin Child Psychol. 2008;37(1):62–104.

    Article  Google Scholar 

  83. Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1404–11.

    Article  PubMed  Google Scholar 

  84. Klomek AB, Mufson L. Interpersonal psychotherapy for depressed adolescents. Child Adolesc Psychiatr Clin N Am. 2006;15(4):959–75.

    Article  PubMed  Google Scholar 

  85. Rossello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol. 1999;67(5):734–45.

    Article  CAS  PubMed  Google Scholar 

  86. American Psychiatric Association, American Academy of Child and Adolescent Psychiatry. The use of medication in treating childhood and adolescent depression: information for patients and families 2010. http://www.parentsmedguide.org/parentsmedguide.pdf.

  87. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1088–96.

    Article  Google Scholar 

  88. Wells KC, Pelham WE, Kotkin RA, Hoza B, Abikoff HB, Abramowitz A, et al. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol. 2000;28(6):483–505.

    Article  CAS  PubMed  Google Scholar 

  89. Curry J, Rohde P, Simons A, Silva S, Vitiello B, Kratochvil C, et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1427–39.

    Article  PubMed  Google Scholar 

  90. March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64(10):1132–43.

    Article  CAS  PubMed  Google Scholar 

  91. Kratochvil CJ, May DE, Silva SG, Madaan V, Puumala SE, Curry JF, et al. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. J Child Adolesc Psychopharmacol. 2009;19(5):519–27.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Birmaher B, McCafferty JP, Bellew KM, Beebe KL, editors. Comorbid ADHD and disruptive behavior disorders as predictors of response in adolescents treated for major depression. Annual Meeting of the American Psychiatric Association; 2000 May; Chicago, IL.

    Google Scholar 

  93. Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40(7):762–72.

    Article  CAS  PubMed  Google Scholar 

  94. Angold A, Costello EJ, Messer SC, Pickles A. Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Methods Psychiatr Res. 1995;5(4):237–49.

    Google Scholar 

  95. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Poznanski EO, Cook SC, Carroll BJ. A depression rating scale for children. Pediatrics. 1979;64(4):442–50.

    CAS  PubMed  Google Scholar 

  97. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

    Article  CAS  PubMed  Google Scholar 

  98. Kovacs M. The Children’s Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21(4):995–8.

    CAS  PubMed  Google Scholar 

  99. Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, et al. The Texas Children’s Medication Algorithm Project: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: tactics. J Am Acad Child Adolesc Psychiatry. 2000;39(7):920–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Dartmouth Hitchcock Medical Center, Dartmouth Geisel School of Medicine, Lebanon, NH, USA

    W. Burleson Daviss M.D.

Authors
  1. W. Burleson Daviss M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Burleson Daviss M.D. .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Dartmouth Hitchcock Medical Center, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire, USA

    W. Burleson Daviss

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Daviss, W.B. (2018). Depressive Disorders and ADHD. In: Daviss, W. (eds) Moodiness in ADHD. Springer, Cham. https://doi.org/10.1007/978-3-319-64251-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64251-2_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64250-5

  • Online ISBN: 978-3-319-64251-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation